ATE110364T1 - SUBSTITUTED QUINOLINES. - Google Patents

SUBSTITUTED QUINOLINES.

Info

Publication number
ATE110364T1
ATE110364T1 AT89900021T AT89900021T ATE110364T1 AT E110364 T1 ATE110364 T1 AT E110364T1 AT 89900021 T AT89900021 T AT 89900021T AT 89900021 T AT89900021 T AT 89900021T AT E110364 T1 ATE110364 T1 AT E110364T1
Authority
AT
Austria
Prior art keywords
stands
pct
carboxy
bond
stand
Prior art date
Application number
AT89900021T
Other languages
German (de)
Inventor
Ian Ahnfelt-Ronne
Erik Torngard Hansen
Dorte Kirstein
Ole Bent Tvaermose Nielsen
Schneur Rachlin
Original Assignee
Leo Pharm Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharm Prod Ltd filed Critical Leo Pharm Prod Ltd
Application granted granted Critical
Publication of ATE110364T1 publication Critical patent/ATE110364T1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14—Radicals substituted by oxygen atoms

Abstract

PCT No. PCT/DK88/00188 Sec. 371 Date Jun. 1, 1990 Sec. 102(e) Date Jun. 1, 1990 PCT Filed Nov. 17, 1988 PCT Pub. No. WO89/05294 PCT Pub. Date Jun. 15, 1989.The present invention relates to hitherto unknown compounds of formula, in which formula R1 stands for hydrogen, straight or branched, saturated or unsaturated, unsubstituted or substituted C1-C8-alkyl, aryl or for ar-C1-C4-alkyl, aryl or an being unsubstituted or substituted phenyl, R2, R3, R4, R5, R6 and R7 are the same or different and stand for hydrogen, halogen, pseudo halogen, cyano, nitro, amino, carboxy, carbalkoxy, carbamyl, hydroxy, alkyl, alkoxy; n and m are the same or different and stand for an integer from 0-6; provided that n cannot be zero when A stands for carboxy and X and Q both stand for a bond; X stands for a bond or for O, S, S(O), S(O)2 or for NR8 where R8 is defined as R1 above; Q stands for a bond of for straight or branched, C1-C6-alkylene; A stands for an acidic group, e.g. for carboxy, 1H-tetrazolyl, a sulphonic acid group, a sulfamyl group, a sulphinic acid group or a hydroxamic acid group. The present compounds are of value in the human and veterinary practice as lipoxygenase inhibitors and/or leukotriene antagonists.
AT89900021T 1987-12-01 1988-11-17 SUBSTITUTED QUINOLINES. ATE110364T1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878728051A GB8728051D0 (en) 1987-12-01 1987-12-01 Chemical compounds

Publications (1)

Publication Number Publication Date
ATE110364T1 true ATE110364T1 (en) 1994-09-15

Family

ID=10627789

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89900021T ATE110364T1 (en) 1987-12-01 1988-11-17 SUBSTITUTED QUINOLINES.

Country Status (16)

Country Link
US (1) US5110819A (en)
EP (1) EP0420844B1 (en)
JP (1) JPH03501477A (en)
KR (1) KR900700454A (en)
AT (1) ATE110364T1 (en)
CA (1) CA1336602C (en)
DE (1) DE3851232T2 (en)
ES (1) ES2011919A6 (en)
GB (1) GB8728051D0 (en)
GR (1) GR1000422B (en)
IE (1) IE64473B1 (en)
NZ (1) NZ227003A (en)
PH (1) PH29985A (en)
PT (1) PT89118B (en)
WO (1) WO1989005294A1 (en)
ZA (1) ZA888763B (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4920132A (en) * 1987-11-03 1990-04-24 Rorer Pharmaceutical Corp. Quinoline derivatives and use thereof as antagonists of leukotriene D4
GB8919504D0 (en) * 1989-08-29 1989-10-11 Leo Pharm Prod Ltd Chemical compounds
US5021576A (en) * 1989-10-27 1991-06-04 American Home Products Corporation 2-Anilino phenylacetic acid derivatives
AU654140B2 (en) * 1990-07-31 1994-10-27 Lilly Industries Limited N-benzyl indoles, processes for their preparation or pharmaceutical compositions containing them
US5281593A (en) * 1990-07-31 1994-01-25 Lilly Industries Limited Certain indole derivatives useful as leukotriene antagonists
WO1994014797A1 (en) * 1992-12-23 1994-07-07 Smithkline Beecham Corporation Quinoline compounds and the treatment of leucotriene related diseases therewith
US5486612A (en) * 1993-12-14 1996-01-23 Eli Lilly And Company N-benzyl dihydroindole LTD4 antagonists
GB9414590D0 (en) * 1994-07-20 1994-09-07 Leo Pharm Prod Ltd Chemical compounds
ES2103180B1 (en) * 1994-08-01 1998-04-01 Menarini Lab PHENYLACETAMIDES WITH ANTAGONIST ACTION OF THE LEUCOTRENEES.
US5602110A (en) * 1994-08-31 1997-02-11 Case Western Reserve University Method and composition for treating cystic fibrosis
EP0725063A1 (en) * 1995-02-01 1996-08-07 Ciba-Geigy Ag Quinoline derivatives
ES2117551B1 (en) * 1995-12-29 1999-04-01 Menarini Lab NAPHTHALENIC QUINOLINS WITH ANTAGONIST ACTION OF THE LEUKOTRENEES, PROCEDURE FOR THE PREPARATION AND USE OF THE SAME.
US5756518A (en) * 1996-04-02 1998-05-26 Kowa Co., Ltd. Phenylene derivatives
JP2004137284A (en) * 1997-06-17 2004-05-13 Kaken Pharmaceut Co Ltd 2-sulfamoylbenzoic acid derivative
AU732106B2 (en) 1997-06-17 2001-04-12 Kaken Pharmaceutical Co., Ltd. 2-sulfamoylbenzoic acid derivatives
US6376671B1 (en) 1997-06-17 2002-04-23 Kaken Pharmaceutical Co., Ltd. 2-sulfamoylbenzoic acid derivatives
ATE216698T1 (en) * 1997-09-26 2002-05-15 Kowa Co TETRAZOLE DERIVATIVES AS LTD4 AND H1 ANTAGONISTS
DE60027420T2 (en) * 1999-04-28 2006-11-16 Aventis Pharma Deutschland Gmbh TRI-ARYL ACID DERIVATIVES AS PPAR RECEPTOR LIGANDS
MXPA02007603A (en) * 2000-03-09 2003-02-24 Aventis Pharma Gmbh Therapeutic uses of ppar mediators.
US7098241B2 (en) 2002-12-16 2006-08-29 Hoffmann-La Roche Inc. Thiophene hydroxamic acid derivatives
JP4875978B2 (en) 2004-03-15 2012-02-15 武田薬品工業株式会社 Aminophenylpropanoic acid derivatives

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4625034A (en) * 1985-02-04 1986-11-25 Usv Pharmaceutical Corp. 1,2-Dihydro; 1,2,3,4-tetrahydro; 5,8 dihydro; and 5,6,7,8-tetrahydroquinoline derivatives
IE58870B1 (en) * 1985-03-08 1993-11-17 Leo Pharm Prod Ltd Pyridine derivatives
US4839369A (en) * 1985-04-16 1989-06-13 Rorer Pharmaceutical Corporation Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments
DK282986A (en) * 1985-06-18 1987-02-24 Merck Frosst Canada Inc SUBSTITUTED QUINOLINE AND PHARMACEUTICAL PREPARATION CONTAINING SUCH A RELATIONSHIP
ATE68789T1 (en) * 1985-10-16 1991-11-15 Merck Frosst Canada Inc 2-SUBSTITUTED QUINOLINES.
EP0219307A3 (en) * 1985-10-16 1987-10-14 Merck Frosst Canada Inc. 2-substituted quinolines
GB2185741B (en) * 1986-01-27 1989-10-25 American Home Prod Heterocyclic sulphonamides
US4904786A (en) * 1986-01-27 1990-02-27 American Home Products Corporation Quinoline compounds as antiallergic and antiinflammatory agents
IE59889B1 (en) * 1986-02-14 1994-04-20 Merck Frosst Canada Inc 2-substituted quinoline dioic acids
EP0271287A3 (en) * 1986-12-11 1990-06-13 Merck Frosst Canada Inc. Quinoline dioic acids and amides
US4920132A (en) * 1987-11-03 1990-04-24 Rorer Pharmaceutical Corp. Quinoline derivatives and use thereof as antagonists of leukotriene D4
DE3814504A1 (en) * 1988-04-29 1989-11-09 Bayer Ag (ALPHA) -SUBSTITUTED 4- (CHINOLIN-2-YL-METHOXY) PHENYL ACETIC ACIDS AND SITES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE IN MEDICAMENTS

Also Published As

Publication number Publication date
ES2011919A6 (en) 1990-02-16
IE64473B1 (en) 1995-08-09
DE3851232T2 (en) 1995-02-02
PT89118B (en) 1993-04-30
IE883419L (en) 1989-06-01
GR1000422B (en) 1992-06-30
JPH03501477A (en) 1991-04-04
WO1989005294A1 (en) 1989-06-15
GB8728051D0 (en) 1988-01-06
EP0420844B1 (en) 1994-08-24
DE3851232D1 (en) 1994-09-29
CA1336602C (en) 1995-08-08
US5110819A (en) 1992-05-05
PH29985A (en) 1996-10-29
KR900700454A (en) 1990-08-13
EP0420844A1 (en) 1991-04-10
ZA888763B (en) 1989-07-26
PT89118A (en) 1988-12-01
NZ227003A (en) 1991-11-26

Similar Documents

Publication Publication Date Title
ATE110364T1 (en) SUBSTITUTED QUINOLINES.
ATE152719T1 (en) CHINOLYLBENZOFURAN DERIVATIVES AS LEUCOTRIEN ANTAGONISTS
DE69512930D1 (en) STILB DERIVATIVES USED AS CYCLOOXYGENASE-2 INHIBITORS
TR199900046T2 (en) Substituted pyridines as selective cyclooxygenase-2 inhibitors.
ATE165825T1 (en) PHENYL HETEROCYCLES AS CYCLOOXYGENASE-2 INHIBITORS
ES2076935T3 (en) COMPOUND OF PIRAZOLOPYRIDINE AND PROCEDURES FOR ITS PREPARATION.
SE8600913L (en) CHEMICAL SOCIETIES
EA199900242A1 (en) ARALKIL AND ARALKYLIDEN-HETEROCYCLIC LACTAMS AND IMIDES
NO913923D0 (en) 17BETA-SUBSTITUTED-4-AZA-5ALFA-ANDROSTAN-3-ON DERIVATIVES AND PROCEDURES IN THE PREPARATION OF THESE
BG100692A (en) New heterocyclic compounds
ATE252572T1 (en) 5-HT1F AGONISTS
HUP9902133A2 (en) Aromatic inhibitors of microsomal triglyceride transfer protein
AR002690A1 (en) DERIVATIVE OF BENCIMIDAZOLE OR SALTS OF THE SAME, PHARMACEUTICAL COMPOSITION, IMMUNOSUPPRESSIVE AGENT AND ANTI-INFLAMMATORY AGENT THAT CONTAIN IT AND PROCEDURES TO PREPARE SUCH DERIVATIVE.
DE69709568T2 (en) Halo-substituted protein kinase C inhibitors
CO5261493A1 (en) PROCEDURE AND COMPOUNDS FOR THE INHIBITION OF MRP1
ATE223376T1 (en) BISARYLCYCLOBUTENE DERIVATIVES AS CYCLOOXYGENASE INHIBITORS
PT982305E (en) The present invention relates to a process for the preparation of the compounds of the general formulas (I) and (II) to the pharmaceutically acceptable excipients.
DK118390A (en) SUBSTITUTED QUINOLINES
ATE191465T1 (en) CARBAMOYLCARBONIC ACID AMIDES
YU53998A (en) Process for making phenyl heterocycles useful as cox-2 inhibitors
RO82161A (en) PROCEDURE FOR THE PREPARATION OF 2- (2-CHLORO-4-CYCLOPROPYLPHENYLIMINO) -IMIDAZOLIDINE
DK0823254T3 (en) Hitherto unknown use of pyrazolopyridine compounds
ES493044A0 (en) A PROCEDURE FOR THE PREPARATION OF BETA-LACTANIC ANTIBACTERIAL AGENTS.
SE9901237D0 (en) Novel use

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee